TrialJAMA oncology2020

Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non-Small Cell Lung Cancer.

Ganessan Kichenadasse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.